Singapore Clinical Trial: A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Adjuvant Chemotherapy Versus Placebo Plus Adjuvant Chemotherapy in Stage IB-IIIA NSCLC Patients with Uncommon EGFR Mutations Following Complete Tumor Resection (REZILIENT4)

Singapore, Sept. 8 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Ad... Read More

Singapore Clinical Trial: Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant monotherapy compared with standard of care in patients with early-stage, resectable non-small cell lung cancer (Stage II-IIIB) harboring tyrosine kinase domain activating HER2 mutations

Singapore, Sept. 8 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant... Read More

Singapore Clinical Trial: A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants

Singapore, Sept. 8 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the ef... Read More

Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Singapore, Sept. 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigat... Read More

Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, Sept. 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate t... Read More

PAM JAYA says Jakarta's tap water remains safe amid ash

Jakarta, Sept. 8 -- Jakarta's public water utility, PAM JAYA, said the capital city's piped water remains safe to drink and meets national standards despite weather conditions and volcanic ash from Mo... Read More

DUSU Election 2026: Dates, key candidates, issues and history of Delhi University Students Union

New Delhi, Sept. 8 -- Delhi University is in full political mode as student union (DUSU) elections, scheduled for next week has set the stage for a contest among major student groups, including ABVP, ... Read More

iPhone 18 Series Launch Date Spain: Will iPhone 18 Pro, iPhone 18 Pro Max, Ultra & Foldable iPhone Expected At September 9 Apple Event; Check Release Date & Time, Pre-Order, Price, Colours & Leaks

India, Sept. 8 -- iPhone 18 Pro Max Launch Date in Spain: Apple is gearing up for one of its most eagerly anticipated iPhone releases in recent years and indeed, the official date of "Surprise and shi... Read More

Vietnam, Russia promote defence cooperation

Moscow, Sept. 8 -- Deputy Prime Minister and Minister of National Defence General Phan Van Giang held a meeting with Russian Minister of Defence Andrey Belousov on September 8, as part of General Secr... Read More

Commissionerate Police introduces shoulder flickering lights for traffic personnel safety

Bhubaneswar, Sept. 8 -- Commissionerate Police introduced shoulder flickering lights for traffic personnel as part of a new initiative to improve their safety and visibility while on duty. The system ... Read More

• ««
• «
• 734
• 735
• 736
• 737
• 738
• 739
• 740
• 741
• 742
• 743
• »
• »»